The U.S. Food and Drug Administration approved a new antiwrinkle treatment that could be the most formidable challenger to date to market leader Botox
.
For about two decades, Botox, now sold by AbbVie Inc., has dominated the aesthetic-drug market it helped pioneer, racking up tens of billions of dollars in sales and successfully fending off challengers.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA Approves Durvalumab Plus Chemo for Biliary Tract CancerThe immune checkpoint inhibitor is already approved for use in lung cancer. Now it is also approved for use in combination with chemotherapy for locally advanced or metastatic biliary tract cancer.
Weiterlesen »
United Airlines may end JFK service without more flightsUnited Airlines has warned the FAA if it doesn't get approved for more flights, it will discontinue service to New York's JFK Airport in October.
Weiterlesen »
The worldwide water-lifting power of plants is enormousThe power expended per year by the world’s plants via evaporation rivals the amount of power generated by all hydroelectric dams, a new study suggests.
Weiterlesen »
Samsung flips off the iPhone 14: ‘Let us know when it folds’After the Apple Event revealed new iPhones and AirPods, rival smartphone maker Samsung went viral with a snarky tweet
Weiterlesen »
Toyota Tundra Sales Outpacing Every Pickup Truck from DetroitStill, though sales of the all-new, full-size, off-road-ready truck from Toyota are up, a sizable gap with domestic rivals remains.
Weiterlesen »
Autocar magazine 7 September 2022: on sale now | AutocarIt's Wednesday, which means there's a brand new issue of Autocar on sale! This week we drive the powerful Range Rover Sport and the new, reinvented Volkswagen ID Buzz 👀 Get your copy now!
Weiterlesen »